Squarepoint’s Labcorp LH Stock Holding History

Squarepoint’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,100	Closed	-$293K	–	4726
2026 Q1	$293K	Buy	+1,100	New	+$298K	﹤0.01%	3733
2025 Q4	–	Sell	-1,500	Closed	-$431K	–	4612
2025 Q3	$431K	Buy	+1,500	New	+$402K	﹤0.01%	3371

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Squarepoint's LH Position: Q2 2026 in Review

Squarepoint increased its Labcorp (LH) stake by 84% in Q2 2026, buying an estimated $31.1M and bringing the position to 258,438 shares worth $72.4M. The position accounts for 0.08% of the portfolio, ranked #245.

Squarepoint first reported a position in LH in Q2 2015 and has held it in 42 quarters since. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Squarepoint held 258,438 shares of Labcorp worth $72.4M as of Q2 2026.
Squarepoint bought 118,273 Labcorp shares in Q2 2026, an estimated $31.1M.
Labcorp made up 0.08% of Squarepoint's portfolio in Q2 2026, its #245 holding.
Squarepoint first reported a position in Labcorp in Q2 2015 and has held it in 42 quarters since.
1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.